Ionis Pharmaceuticals, Inc. Common Stock insider trading

IONSfinancial statementsForm 4 filings on EDGAR420 transactions since Nov 16, 2024

From August 19, 2026 to November 16, 2026, 1 insider at Ionis Pharmaceuticals, Inc. Common Stock bought $148K of stock in the open market, and 2 sold $61K. Officers and directors accounted for $148K of purchases and $61K of sales. The last reported transaction was an open-market buy by Hayden Michael R on November 10, 2026.

The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through November 13, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.

Stock price and insider activity

Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.

IONS daily priceSplit-adjusted prices in US dollars

Bought $148KSold $61KAug 19, 2026 – Nov 16, 2026

Nov 13, 2026O $27.30 · H $29.09 · L $27.25 · C $29.06Bought $0 (0)Sold $0 (0)
$25$35$46$56$662026-08-19: open $60.11, high $61.36, low $59.61, close $60.802026-08-20: open $60.03, high $60.41, low $58.60, close $58.762026-08-21: open $59.64, high $60.92, low $59.06, close $59.742026-08-24: open $60.54, high $62.07, low $59.70, close $62.042026-08-25: open $62.53, high $64.19, low $62.19, close $63.572026-08-26: open $63.50, high $63.55, low $62.44, close $63.362026-08-27: open $63.48, high $63.48, low $62.34, close $62.432026-08-28: open $60.62, high $61.69, low $60.35, close $61.052026-08-31: open $61.07, high $61.07, low $59.70, close $60.362026-09-01: open $60.37, high $60.99, low $59.78, close $59.882026-09-02: open $60.25, high $61.77, low $59.78, close $61.332026-09-03: open $60.42, high $60.42, low $57.47, close $58.132026-09-04: open $58.36, high $58.96, low $57.78, close $58.092026-09-08: open $52.15, high $57.43, low $52.15, close $56.712026-09-09: open $56.38, high $56.96, low $55.70, close $56.022026-09-10: open $55.75, high $55.77, low $54.91, close $55.652026-09-11: open $55.94, high $56.16, low $54.16, close $54.212026-09-14: open $54.88, high $55.50, low $51.31, close $51.442026-09-15: open $51.37, high $51.37, low $46.72, close $47.252026-09-16: open $47.38, high $47.59, low $44.66, close $44.842026-09-17: open $46.68, high $47.42, low $45.75, close $46.752026-09-18: open $46.75, high $46.75, low $44.27, close $44.442026-09-21: open $44.95, high $45.25, low $44.20, close $44.902026-09-22: open $44.96, high $46.13, low $44.44, close $45.752026-09-23: open $46.23, high $46.41, low $43.01, close $43.932026-09-24: open $43.77, high $44.60, low $43.25, close $43.812026-09-25: open $44.25, high $45.28, low $43.62, close $44.502026-09-28: open $44.56, high $46.95, low $44.06, close $45.572026-09-29: open $45.53, high $46.46, low $45.39, close $45.892026-09-30: open $46.07, high $46.25, low $44.60, close $44.652026-10-01: open $44.63, high $45.95, low $43.96, close $44.002026-10-02: open $44.17, high $44.17, low $43.24, close $43.542026-10-05: open $43.75, high $43.96, low $42.63, close $43.502026-10-06: open $44.19, high $44.67, low $43.17, close $44.002026-10-07: open $43.75, high $44.26, low $43.53, close $44.162026-10-08: open $43.76, high $44.19, low $42.79, close $43.302026-10-09: open $43.21, high $45.72, low $43.12, close $45.282026-10-12: open $45.37, high $45.46, low $43.62, close $43.672026-10-13: open $43.55, high $43.58, low $42.36, close $42.382026-10-14: open $42.22, high $43.47, low $42.13, close $42.702026-10-15: open $43.58, high $44.71, low $43.42, close $44.122026-10-16: open $44.53, high $44.65, low $42.80, close $42.942026-10-19: open $43.33, high $44.54, low $43.00, close $44.382026-10-20: open $44.45, high $45.48, low $44.01, close $45.402026-10-21: open $45.55, high $45.76, low $44.26, close $44.272026-10-22: open $45.02, high $45.15, low $43.41, close $43.912026-10-23: open $43.80, high $43.80, low $42.58, close $42.932026-10-26: open $43.00, high $43.92, low $42.76, close $43.422026-10-27: open $43.23, high $44.10, low $43.02, close $43.962026-10-28: open $43.16, high $44.95, low $43.05, close $44.902026-10-29: open $45.57, high $45.84, low $44.04, close $44.392026-10-30: open $44.69, high $45.12, low $43.27, close $43.522026-11-02: open $43.66, high $43.91, low $41.19, close $41.242026-11-03: open $41.26, high $41.83, low $40.26, close $40.422026-11-04: open $41.38, high $41.53, low $39.33, close $40.152026-11-05: open $40.31, high $40.50, low $38.31, close $38.802026-11-06: open $39.02, high $40.00, low $38.53, close $39.422026-11-09: open $32.27, high $32.58, low $27.75, close $31.002026-11-10: open $30.31, high $30.49, low $27.77, close $28.192026-11-11: open $28.60, high $29.42, low $28.25, close $28.332026-11-12: open $28.07, high $28.56, low $27.28, close $27.312026-11-13: open $27.30, high $29.09, low $27.25, close $29.06Insider purchases / sales · USD$200K$0−$200K2026-10-16: 0 purchases ($0), 2 sales ($61K)2026-11-10: 1 purchases ($148K), 0 sales ($0)Aug 19Sep 10Oct 2Oct 23Nov 13

purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.

Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 13, 2026. Insider data through Nov 16, 2026. Prices are adjusted for splits; transaction values are reported dollars.

Every transaction

420 transactions from November 16, 2024 to November 16, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Nov 10, 2026Hayden Michael RDirectoropen-market buyindirect5,000$29.64$148K27,000Nov 13, 2026
Oct 16, 2026Devers Shannon L.EVP, Chief Human Resources Ofcopen-market sale1,357$43.54$59K17,811Oct 19, 2026
Oct 16, 2026Swayze EricEVP Researchopen-market saleindirect53$43.54$2K390Oct 19, 2026
Oct 15, 2026Devers Shannon L.EVP, Chief Human Resources Ofcoption exercise2,820$0.00—19,168Oct 19, 2026
Oct 15, 2026Swayze EricEVP Researchoption exerciseindirect125$0.00—443Oct 19, 2026
Aug 31, 2026Bennett C FrankEVP, Chief Scientific Officerother110$51.31$6K60,128Sep 2, 2026
Aug 31, 2026O'Neil Patrick R.EVP CLO & General Counselother63$51.31$3K59,205Sep 2, 2026
Aug 31, 2026Monia Brett PChief Executive Officer, Directorother98$51.31$5K242,760Sep 2, 2026
Aug 31, 2026Birchler BrianEVP, Corp and Development Opsother58$51.31$3K102,883Sep 2, 2026
Jul 31, 2026Hayden Michael RDirectoropen-market buyindirect5,000$51.60$258K24,000Jul 31, 2026
Jul 30, 2026Hayden Michael RDirectoropen-market buyindirect15,000$53.38$801K19,000Jul 31, 2026
Jul 15, 2026Herman Joan EDirectoroption exercise5,220$0.00—51,306Jul 17, 2026
Jul 15, 2026Berthelsen Spencer RDirectoroption exercise5,220$0.00—161,233Jul 17, 2026
Jul 7, 2026Bennett C FrankEVP, Chief Scientific Officeropen-market sale10b5-15,536$83.58$463K75,018Jul 9, 2026
Jul 7, 2026Bennett C FrankEVP, Chief Scientific Officerotherindirect15,000$0.00—15,000Jul 9, 2026
Jul 7, 2026Bennett C FrankEVP, Chief Scientific Officeropen-market sale10b5-1indirect15,000$85.46$1M0Jul 9, 2026
Jul 7, 2026Diaz Allene M.Directoroption exercise10,111$47.11$476K13,922Jul 9, 2026
Jul 7, 2026Diaz Allene M.Directoropen-market sale10b5-110,111$85.42$864K3,811Jul 9, 2026
Jul 7, 2026Kordasiewicz Holly B.EVP, Chief Development Officeropen-market sale10b5-1362$84.30$31K22,096Jul 9, 2026
Jul 1, 2026Klein Joseph IIIDirectoroption exercise11,518$39.94$460K22,532Jul 6, 2026
Jul 1, 2026Klein Joseph IIIDirectoropen-market sale10b5-199$79.45$8K22,433Jul 6, 2026
Jul 1, 2026Klein Joseph IIIDirectoropen-market sale10b5-111,419$79.04$903K11,014Jul 6, 2026
Jun 26, 2026Baroldi JosephEVP, Chief Business Officeroption exerciseindirect3,866$56.78$220K8,535Jun 30, 2026
Jun 26, 2026Baroldi JosephEVP, Chief Business Officeroption exerciseindirect1,769$32.60$58K10,304Jun 30, 2026
Jun 26, 2026Baroldi JosephEVP, Chief Business Officeropen-market sale10b5-1indirect5,635$80.16$452K4,669Jun 30, 2026
Jun 26, 2026O'Neil Patrick R.EVP CLO & General Counselopen-market sale10b5-13,069$80.00$246K61,470Jun 30, 2026
Jun 26, 2026Schneider EugeneEVP, Chf Clinical Develop Ofcroption exercise26,000$60.89$2M103,114Jun 30, 2026
Jun 26, 2026Schneider EugeneEVP, Chf Clinical Develop Ofcropen-market sale10b5-126,000$81.05$2M77,114Jun 30, 2026
Jun 26, 2026Monia Brett PChief Executive Officer, Directoroption exercise50,000$56.78$3M295,571Jun 26, 2026
Jun 26, 2026Monia Brett PChief Executive Officer, Directoropen-market sale10b5-150,000$80.59$4M245,571Jun 26, 2026
Jun 25, 2026Monia Brett PChief Executive Officer, Directoroption exercise21,072$32.60$687K266,643Jun 26, 2026
Jun 25, 2026Monia Brett PChief Executive Officer, Directoropen-market sale10b5-121,072$78.49$2M245,571Jun 26, 2026
Jun 25, 2026Swayze EricEVP Researchopen-market sale10b5-110,602$79.18$839K21,759Jun 26, 2026
Jun 24, 2026Monia Brett PChief Executive Officer, Directoroption exercise14,565$32.60$475K260,136Jun 26, 2026
Jun 24, 2026Monia Brett PChief Executive Officer, Directoropen-market sale10b5-114,565$78.41$1M245,571Jun 26, 2026
Jun 15, 2026Berthelsen Spencer RDirectoroption exercise8,000$24.42$195K164,013Jun 16, 2026
Jun 15, 2026Berthelsen Spencer RDirectoropen-market sale10b5-18,000$73.49$588K156,013Jun 16, 2026
Jun 12, 2026Kordasiewicz Holly B.EVP, Chief Development Officeroption exercise7,951$60.89$484K30,409Jun 16, 2026
Jun 12, 2026Kordasiewicz Holly B.EVP, Chief Development Officeroption exercise21,000$60.89$1M51,409Jun 16, 2026
Jun 12, 2026Kordasiewicz Holly B.EVP, Chief Development Officeroption exercise12,000$32.60$391K63,409Jun 16, 2026
Jun 12, 2026Kordasiewicz Holly B.EVP, Chief Development Officeroption exercise19,895$56.78$1M83,304Jun 16, 2026
Jun 12, 2026Kordasiewicz Holly B.EVP, Chief Development Officeropen-market sale10b5-141,004$73.09$3M42,300Jun 16, 2026
Jun 12, 2026Kordasiewicz Holly B.EVP, Chief Development Officeropen-market sale10b5-119,842$74.05$1M22,458Jun 16, 2026
Jun 1, 2026Berthelsen Spencer RDirectoroption exercise8,000$24.42$195K164,013Jun 3, 2026
Jun 1, 2026Berthelsen Spencer RDirectoropen-market sale10b5-18,000$75.67$605K156,013Jun 3, 2026
May 14, 2026Monia Brett PChief Executive Officer, Directoroption exercise3,220$32.60$105K245,882May 15, 2026
May 14, 2026Monia Brett PChief Executive Officer, Directoropen-market sale10b5-13,220$78.68$253K242,662May 15, 2026
May 13, 2026Monia Brett PChief Executive Officer, Directoroption exercise1,316$32.60$43K243,978May 15, 2026
May 13, 2026Monia Brett PChief Executive Officer, Directoropen-market sale10b5-11,316$78.01$103K242,662May 15, 2026
May 4, 2026Loscalzo JosephDirectoroption exercise10,968$38.06$417K47,298May 6, 2026

Who the insiders are

Everyone who reported a transaction since November 16, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.

InsiderRoleLast transactionKindShares heldBought, 12 monthsSold, 12 monthsSales under a plan
Monia Brett PChief Executive Officer, DirectorAug 31, 2026other242,760—$30M (13)11 of 13
Hougen Elizabeth LEVP, Finance & CFOMar 17, 2026open-market sale82,660—$18M (5)3 of 5
Bennett C FrankEVP, Chief Scientific OfficerAug 31, 2026other60,128—$17M (10)8 of 10
Devers Shannon L.EVP, Chief Human Resources OfcOct 16, 2026open-market sale17,811—$8M (13)11 of 13
Loscalzo JosephDirectorMay 4, 2026option exercise47,298—$6M (4)4 of 4
Klein Joseph IIIDirectorJul 1, 2026option exercise22,532—$5M (10)10 of 10
Swayze EricEVP ResearchOct 16, 2026open-market sale21,759—$5M (9)5 of 9
Diaz Allene M.DirectorJul 7, 2026option exercise13,922—$5M (4)4 of 4
Kordasiewicz Holly B.EVP, Chief Development OfficerJul 7, 2026open-market sale22,096—$5M (4)3 of 4
Schneider EugeneEVP, Chf Clinical Develop OfcrJun 26, 2026option exercise103,114—$4M (4)2 of 4
Jenne KyleEVP, Chf GL Pdt Str OfcrApr 16, 2026open-market sale23,713—$3M (4)2 of 4
Herman Joan EDirectorJul 15, 2026option exercise51,306—$3M (2)0 of 2
Baroldi JosephEVP, Chief Business OfficerJun 26, 2026option exercise44,909—$3M (11)7 of 11
Wender Joseph HDirectorDec 1, 2025open-market sale16,000—$2M (2)2 of 2
O'Neil Patrick R.EVP CLO & General CounselAug 31, 2026other59,205—$2M (4)2 of 4
Birchler BrianEVP, Corp and Development OpsAug 31, 2026other102,883—$1M (3)0 of 3
Hayden Michael RDirectorNov 10, 2026open-market buy54,298$1M (3)——
Berthelsen Spencer RDirectorJul 15, 2026option exercise161,233—$1M (2)2 of 2
Parshall B LynneDirectorApr 15, 2026open-market sale51,878—$795K (3)3 of 3
Geary Richard SEVP, Chief Development OfficerNov 6, 2025option exercise74,395———
Yang Michael J.DirectorJan 15, 2026option exercise7,940———

Questions

Are Ionis Pharmaceuticals, Inc. Common Stock insiders buying or selling?

Over the twelve months to November 16, 2026, 18 insiders at Ionis Pharmaceuticals, Inc. Common Stock sold $120M of stock in the open market, all by officers and directors, and 1 insider bought $1M, all by officers and directors. Net, insiders sold $119M. Only open-market purchases and sales are counted.

Who sold the most Ionis Pharmaceuticals, Inc. Common Stock stock in the last year?

Monia Brett P (Chief Executive Officer, Director) sold $30M in 13 open-market sales over the twelve months to November 16, 2026.

Do Ionis Pharmaceuticals, Inc. Common Stock executives sell under 10b5-1 plans?

79 of the 107 open-market sales in the last twelve months (74%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.

What counts as insider buying here?

Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.

More on Ionis Pharmaceuticals, Inc. Common Stock

From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.